Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 641 - 650 of 742 studies

Risk Stratification of Interstitial Lung Abnormalities using Hyperpolarised Xenon MRI and blood biomarkers

MyeloFiT: Myeloproliferative Neoplasms – Imaging-based assessment of Fibrosis and Thrombosis Risk (MyeloFiT)

Oxford Genetic Frontotemporal Dementia Initiative 3 (GENFI)

Cancer and neoplasms

A First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ- 88549968, a T-cell Redirecting Bispecific Antibody for CALR mutated Myeloproliferative Neoplasms

Interrogating immune- tumour interactions within the central nervous system

A phase 1 study to assess the safety and immunogenicity of R21/Matrix-MTM administered in an escalating dose, multi-prime vaccination schedule in healthy adults (VAC096)

Oral and Gastrointestinal

A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23Pathway to Establish Efficacy in Pediatric Crohn’s Disease (MACARONI-23)

Renal and Urogenital

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of RO7434656, An Antisense Inhibitor Of Complement Factor B, In Patients With Primary IgA Nephropathy At High Risk Of Progression (IMAGINATION)

A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

Oral and Gastrointestinal

A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn’s Disease (MACARONI-23)